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We performed a genomewide scan for genes that predispose to low serum HDL cholesterol (HDL-C) in 25 well-
defined Finnish families that were ascertained for familial low HDL-C and premature coronary heart disease. The
potential loci for low HDL-C that were identified initially were tested in an independent sample group of 29 Finnish
families that were ascertained for familial combined hyperlipidemia (FCHL), expressing low HDL-C as one com-
ponent trait. The data from the previous genome scan were also reanalyzed for this trait. We found evidence for
linkage between the low-HDL-C trait and three loci, in a pooled data analysis of families with low HDL-C and
FCHL. The strongest statistical evidence was obtained at a locus on chromosome 8q23, with a two-point LOD
score of 4.7 under a recessive mode of inheritance and a multipoint LOD score of 3.3. Evidence for linkage also
emerged for loci on chromosomes 16q24.1-24.2 and 20q13.11, the latter representing a recently characterized
region for type 2 diabetes. Besides these three loci, loci on chromosomes 2p and 3p showed linkage in the families
with low HDL-C and a locus on 2ptel in the families with FCHL.
Low serum HDL cholesterol (HDL-C), or hypo-a-li-
poproteinemia, is the most frequently diagnosed dyslip-
idemia in patients with premature coronary heart disease
(CHD) (Genest et al. 1992). The common form of low
HDL-C that is associated with CHD is a typical complex
disorder in which several genes and environmental fac-
tors affect the phenotype. Several candidate genes have
been associated with low HDL-C in multiple sample
groups (Davignon and Genest 1998). One of the most
interesting findings indicated that allelic variants in the
ATP-binding cassette transporter 1 gene (ABC1 [MIM
205400; MIM 600046]) contribute to low HDL-C in
four French-Canadian families (Brooks-Wilson et al.
1999; Rust et al. 1999). However, the significance of this
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or other candidate genes for the common form of low
HDL-C has not been established. Here we report anal-
yses of the first genome scan for low serum HDL-C
performed in multiplex families from Finland. The sam-
ple group was selected to restrict both environmental
and genetic heterogeneity. Finns descend from small
founder populations that share a relatively homogeneous
gene pool and environment (Peltonen et al. 1999). Ex-
cellent epidemiological data sets are an additional ad-
vantage, since these facilitate the adoption of age- and
sex-specific population percentiles when defining affec-
tion status in family members (Porkka et al. 1994; Var-
tiainen et al. 1994).
The sample group with low HDL-C was collected
in Helsinki and Turku University Central Hospitals in
Finland. A total of 176 individuals, from 20 well-
defined families with low HDL-C, were included in
stage 1, and 5 additional families, with 43 individuals,
were included in stage 2. Inclusion criteria for the
probands with low HDL-C were an age of 30–60
years for both men and women, HDL-C levels !10th
age- and sex-specific percentile of the Finnish popu-
lation, and CHD that had been verified by either cor-
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Table 1
Clinical Characteristics of the Families with Low HDL-C
Affecteda
( )np 104
Unaffected
( )np 115
Age (years) 49.3  15.7 43.7  17.2
Sex (% males) 47 50
BMI (kg/m2) 26.8  4.1 24.7  4.1
HDL-C (mmol/liter) .86  .16 1.37  .34
TGs (mmol/liter) 1.69  .81 1.22  .59
TC (mmol/liter) 5.27  .97 5.46  1.11
Apolipoproteins:
A-I (mg/dl) 120  16 147  25
A-II (mg/dl) 34  6 38  6
NOTE.—All values except those for sex are expressed as mean 
SD. The affected group includes 25 probands with low HDL-C and
79 hypo-a-lipoproteinemic family members.
a HDL-C levels !10th age- and sex-specific percentile.
Table 2
Two-Point and Multipoint Evidence for Linkage to Chromosome
8q23
LOCATION POSITIONa
LOD SCOREb
SIMWALK
STATISTICS AdPairwisec ASP
GAAT1A4 .0 .0 (.50)/.3 (.26) .2/.5 1.3
D8S1132 8.9 2.3 (.10)/4.7 (.06) 1.4/3.1 3.3
D8S592 14.9 .1 (.32)/1.0 (.18) .2/.9 2.0
NOTE.—For statistical analyses, see the legend for figure 1.
a Distance (in cM) from the first marker.
b The first LOD score is that for sample group with low HDL-C
and the second (i.e., after the slash mark) is that for the pooled sample
group.
c Maximum LOD scores for the two-point linkage analysis. The
recombination fractions are given in parentheses.
d Results of the nonparametric-linkage analysis from Simwalk, ver-
sion 2.80, for the pooled sample group. Statistic A is most powerful
at detecting linkage to a recessive trait, statistic B is most powerful at
detecting linkage to a dominant trait, and statistic C is a more general
statistic that indicates if a few founder-alleles are overly represented
among affecteds.
onary angiography (150% stenosis of one or more
coronary arteries) or myocardial infarction. All of the
three following criteria had to be fulfilled for the di-
agnosis of myocardial infarction: (1) typical clinical
symptoms; (2) definite electrocardiographic findings,
according to the Minnesota coding (World Health Or-
ganization criteria) (Rose et al. 1982); and (3) elevated
levels of the creatine-kinase enzyme, CK, and its car-
diac isoenzyme, CK-MB. In addition to the probands,
seven siblings of the probands and two parents had
CHD. Additional lipid criteria for the probands were
total cholesterol (TC) !6.3 mmol/liter in men and !6.0
mmol/liter in women and triglycerides (TGs) !2.3
mmol/liter in both sexes. To be selected for the study,
the proband must have at least three accessible first-
degree relatives. Exclusion criteria for the probands
were type 1 or type 2 diabetes mellitus (DM), signif-
icant hepatic or renal diseases, untreated hypothyreo-
sis, familial hypercholesterolemia, or a BMI 130 kg/
m2 (table 1). The lipid profiles shown in table 1 are
consistent with those described elsewhere (Brooks-
Wilson et al. 1999). The affected family members were
identified as having low HDL-C, by use of the Finnish
age- and sex-specific 10th population percentiles.
Each study subject provided written informed consent
prior to participating in the study. Any lipid-lowering
medication was interrupted for 4 wk before the blood
samples were taken. All samples were collected in ac-
cordance with the Helsinki declaration, and the ethics
committees of the participating centers approved the
study design. Serum TC, TGs, and HDL-C were mea-
sured as described elsewhere (Pajukanta et al. 1998,
1999). Apolipoproteins A-I and A-II were measured
by an immunoturbidimetric method with commercial
kits (Boehringer-Mannheim).
In stage 1, a total of 358 microsatellite markers (the
modified Weber screening set, version 9.0) were geno-
typed. The genotyping was performed using LI-COR
DNA 4200 Genetic Analyzer. The markers for denser
maps were selected from the Genome Database; Co-
operative Human Linkage Center; Center for Medical
Genetics, Marshfield Medical Research Foundation;
Genetic Location Database; and Ge´ne´thon databases.
Parametric linkage and nonparametric affected-sib-
pair (ASP) analyses were performed for all markers
(for details of the statistical analyses, see the legend
for fig. 1). The complete two-point linkage results for
all markers are available from our Web site (UCLA
Human Genetics).
In stage 1, two-point LOD scores 11.0 were ob-
tained for markers on chromosomes 1–3, 6–9, and
16–20. Figure 1 shows these results under either a
parametric recessive mode of inheritance or the ASP
analysis. The highest LOD score, 2.9 (recombination
fraction ), was observed with the chromo-[v]p 0.10
some 3 marker D3S4545 by use of a dominant mode
of inheritance. On chromosomes 1 and 9, two sepa-
rate regions produced LOD scores 11.0. These two
regions were located 72 cM and 10.7 cM apart, re-
spectively. One of the regions on chromosome 1, lo-
cated in the vicinity of the apolipoprotein A-II gene
(APOA2 [MIM 107670]), produced a LOD score of
2.1 with D1S2844. No additional markers were geno-
typed in this particular region, since it was fine
mapped in our previous studies (Pajukanta et al. 1998;
Lilja et al., in press).
In stage 2, the chromosomal regions that showed two-
point LOD scores 11.0 in stage 1 were further studied
by genotyping 67 additional markers and including five
additional families with low HDL-C (fig. 2). The most
significant linkage results on chromosomes 8, 16, 20,
Reports 1335
Figure 1 Highest two-point LOD scores in stage 1, for the sample group with low HDL-C, on each chromosome, as determined by use
of either a recessive mode of inheritance or an ASP analysis. A dominant mode of inheritance yielded LOD scores that were typically slightly
lower. The MLINK program of the LINKAGE package (Lathrop et al. 1984), version FASTLINK 4.1P (Cottingham et al. 1993; Scha¨ffer et al.
1994), was used to perform the parametric linkage analyses. The parametric linkage analyses were performed with a dominant and recessive
mode of inheritance by use of an affecteds-only strategy. Gene frequencies (reflecting an estimated population prevalence of ∼1%) of 0.4% and
8% were used for the dominant and recessive mode of inheritance. For each marker, the allele frequencies were estimated from all individuals,
by use of the DOWNFREQ program (Go¨ring and Terwilliger 2000b). The ASP analysis was performed using the SIBPAIR program (Kuokkanen
et al. 1996) of the ANALYZE package (Go¨ring and Terwilliger 2000a). The two-point analyses were performed using the AUTOSCANprogram,
a helper program that enables a genomewide scan by a single computer analysis. Multipoint analyses were performed with the Simwalk program,
version 2.80 (Sobel and Lange 1996). The Mendelian errors were checked with the PedCheck program (O’Connell and Weeks 1998). The
observed inconsistencies were handled by rereading raw gel data; if errors still remained, the genotypes of the particular subjects involved were
coded as zeros. On chromosomes 1 and 9, two separate regions produced LOD scores 11.0 and are indicated as 1a and 1b and 9a and 9b,
respectively. The recombination fraction shown is that of the two-point maximum LOD score in the parametric linkage analysis. The position
given is the distance (in cM) from pter, for each marker.
2p, and 3 are given in tables 2–5. For the remaining
chromosomal regions, no further evidence for linkage
was obtained in stage 2.
To further analyze the chromosomal regions on chro-
mosomes 8, 16, 20, 2p, and 3, we performed linkage
analyses, by use of low HDL-C as an affection status,
in an independent sample group of 29 well-defined
Finnish families with familial combined hyperlipidemia
(FCHL) (table 6) (Pajukanta et al. 1999). In addition
to elevated TC and TGs, low HDL-C is one of the
component traits of FCHL. When coding the family
members of the families with FCHL as affected, we
used the same 10th-percentile HDL-C trait as had been
used in our HDL-C scan. The data collection, labo-
ratory measurements, and phenotype determinations
for the families with low HDL-C or FCHL were per-
formed in the same center, thereby making clinical and
biochemical data in these two sample groups fully
compatible.
When we analyzed the genome-scan data from the
families with FCHL for the low-HDL-C trait, the three
chromosomal regions on chromosomes 8q, 16q, and 20q
that were identified in the families with low HDL-C
provided some evidence for linkage. On chromosome
8q23, maximum LOD scores were observed with the
same marker, D8S1132, in both the sample groups with
low HDL-C and the sample groups with FCHL. The
highest two-point LOD score in the families with FCHL
was 1.6 ( ). On chromosome 16, D16S518vp 0.08
yielded a two-point LOD score of 1.1 ( ) andvp 0.14
D16S403, located 67 cM centromeric from D16S518,
yielded an ASP-LOD score of 1.1 in the sample group
with FCHL. On chromosome 20, an ASP-LOD score of
1.7 was obtained with D20S481, located 36 cM cen-
tromeric from D20S171, which is the peak marker in
the families with lowHDL-C. The highest pairwise LOD
scores for each chromosome in the sample group with
FCHL are presented in figure 2.
To test if additional loci for low HDL-C could be
identified in the families with FCHL, we reanalyzed
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Figure 2 Highest two-point LOD scores in stage 2, for the three sample groups, on each chromosome. Gray columns show the two-point
results for the sample group with low HDL-C, white columns show the results for the sample group with FCHL, and black columns show the
results for the pooled sample group. The chromosome numbers are given below the X-axis. The boxes indicate the chromosomes on which the
identified loci were supported by the pooled data analyses. On chromosome 2, two separate regions produced LOD scores 12.0 and are indicated
as 2ptel and 2p. The complete linkage results for stage 2 are available from our Web site (UCLA Human Genetics). The markers that produced
the highest LOD scores separately for each sample group are given below each chromosome. The recombination fraction and position are as
explained in the legend for figure 1.
the data from the previous genome scan that was per-
formed with 370 microsatellite markers (the Weber
screening set, version 6.0) in 29 families with FCHL
(Pajukanta et al. 1999). Using the 10th-percentile
HDL-C trait as an affection status in the families with
FCHL, we observed a promising finding for the low
HDL-C on chromosome 2ptel, with D2S423, which
yielded an ASP-LOD score of 3.4, and D2S2952,
which is located 4.2 cM telomeric and which yielded
a LOD score of 1.2 ( ). For the families withvp 0.12
low HDL-C, D2S423 yielded a two-point LOD score
of 0.0 ( ), and D2S2952 yielded a LOD scorevp 0.48
of 0.9 ( ) (table 7).vp 0.12
A pooled data analysis of the families with low
HDL-C and FCHL was performed using low HDL-C
as the diagnostic trait. The highest LOD score, 4.7
( ), was obtained with D8S1132, on chro-vp 0.06
mosome 8q23. A multipoint analysis provided sup-
portive evidence, with LOD scores 13.0 (table 2). On
chromosome 16, D16S3091 yielded a two-point LOD
score of 2.2 ( ) in the pooled data analysis,vp 0.12
yielding some additional evidence for this region (ta-
ble 3). On chromosome 20, a LOD score of 1.9
( ) was obtained with D20S171 (table 4). Thevp 0.14
chromosomal regions identified in only one of the
sample groups (chromosomes 2p and 3p, in the fam-
ilies with low HDL-C, and 2ptel, in the families with
FCHL) did not gain any further support in these
pooled data analyses. The HOMOG program (Ott
1991) provided no statistical evidence for locus het-
erogeneity among families with low HDL-C or FCHL
for any tested marker.
Although our study design of the genomewide scan
was selected to identify linked regions for a qualitative
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Table 3
Two-Point and Multipoint Evidence for Linkage to Chromosome
16q24.1-24.2
LOCATION POSITION
LOD SCORE
SIMWALK
STATISTICS CPairwise ASP
D16S3040 .0 .1 (.32) .1 1.1
D16S505a 4.5 1.5 (.12)/1.3 (.18) 1.8/1.5 1.2
D16S3091a 6.7 1.9 (.08)/2.2 (.12) 1.8/1.9 1.2
D16S402 9.1 .2 (.34) .6 .9
D16S3061 17.0 .0 (.50) .0 .5
NOTE.—The position and linkage results are as explained in table 2.
a Also genotyped in the sample group with FCHL.
Table 4
Two-Point and Multipoint Evidence for Linkage to Chromosome
20q13.11
LOCATION POSITION
LOD SCORE
SIMWALK
STATISTICS APairwise ASP
D20S120 .0 .8 (.20) .9 1.2
D20S102 3.5 .4 (.20) .4 1.1
D20S171a 8.7 1.3 (.16)/1.9 (.14) 1.3/1.4 1.7
D20S94 11.0 .4 (.26) .3 1.4
D20S173 11.1 .6 (.20) .2 1.4
NOTE.—The position and linkage results are as explained in table 2.
a Also genotyped in the sample group with FCHL.
Table 5
Two-Point and Multipoint Evidence for Linkage to Chromosomes 2p and 3p
LOCATION POSITION
LOD SCORE
SIMWALK
STATISTICS BPairwise ASP
Chromosome 2p:
D2S441a .0 1.0 (.14)/1.2 (.16) .6/.7 1.3
D2S1394a 3.0 2.1 (.10)/1.1 (.20) 1.8/1.1 1.5
D2S286 6.2 .4 (.20) .4 1.2
D2S2114 7.9 .1 (.28) .0 1.0
Chromosome 3p:
D3S3050b .0 .1 (.30) .0 .6
D3S1620 .8 .0 (.50) .0 .7
D3S1304a 8.6 2.1 (.06)/1.9 (.12) 1.0/1.2 1.1
D3S4545 12.5 .5 (.22) .7 1.1
D3S1597 16.2 .0 (.50) .0 .5
NOTE.—Linkage evidence was obtained mainly from the families with low HDL-C. The
position and linkage results are as explained in table 2.
a Also genotyped in the sample group with FCHL.
b Genotyped only in the sample group with FCHL.
trait, we also analyzed the quantitative measures, HDL-
C and TGs, by variance-component methods that util-
ized SOLAR version 1.6.7 (Almasy and Blangero 1998).
Additional covariates in the model were sex, age, BMI,
ascertainment status (i.e., family with HDL-C or FCHL),
and proband status. A logarithmic transformation of the
variable was used if needed. No significant linkage re-
sults emerged from these analyses. For HDL-C, the high-
est LOD score, 1.94, was obtained on chromosome 13
with D13S1493 in a two-point analysis. (The qualitative
analysis for this marker resulted in a LOD score of 1.32
in the pooled sample group.) For TGs, the highest LOD
score, 1.52, was obtained on chromosome 8 in a mul-
tipoint analysis, 50 cM from the p-telomere. (The qual-
itative analysis for this region did not show positive re-
sults.) This TG region is located ∼70 cM from the peak
linkage markers on chromosome 8q23, which were ob-
tained using the qualitative analysis. All results for the
variance-component analyses are available from our
Web site (UCLA Human Genetics). The genotyping
strategy was designed to maximize the information ob-
tained from the affected individuals in the large pedi-
grees. The variance-component analyses can therefore
use only the variation within this group, thus reducing
our power to detect loci with this method.
We also investigated the contribution of the ABC1
gene to low HDL-C in the families with low HDL-C.
Two markers, D9S257 and D9S938, that flank the
ABC1 region yielded LOD scores of 1.8 ( )vp 0.06
and 1.3 ( ). Results of the family-based as-vp 0.06
sociation analyses—haplotype-based haplotype rela-
tive risk and transmission/disequilibrium tests (Ter-
williger and Ott 1992)—were nonsignificant. Next,
we constructed haplotypes (D9S53-ABC1-D9S306-
D9S1866-D9S938-D9S1784-D9S1677) that spanned
a 21.8-cM region, and we monitored for shared hap-
lotypes among the affected family members. Only five
families revealed potential cosegregation, and, con-
sequently, genomic DNA from the five probands was
subjected to sequencing of the coding region of ABC1.
Sequence analyses identified four polymorphisms that
have previously been characterized: the sequence var-
iants corresponding to R219K, in exon 7; V825I, in
exon 17; I883M, in exon 18; and R1587K, in exon
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Table 7
Two-Point and Multipoint Evidence for Linkage to Chromosome
2ptel
LOCATION POSITION
LOD SCORE
SIMWALK
STATISTICS BPairwise ASP
D2S1780 .0 .0 (.50) .0/.0 .8
D2S2952a 6.0 1.2 (.10)/1.4 (.18) .7/1.1 1.4
D2S423a 10.2 2.8 (.0)/1.1 (.18) 3.4/.5 1.5
D2S1400a 15.7 .7 (.12)/.1 (.34) .4/.0 1.2
NOTE.—Linkage evidence was obtained mainly from the families
with FCHL. The position and linkage results are as explained in table
2, except that, in the “LOD Score” columns, the first LOD score is
that for the sample group with FCHL and second (i.e., after the slash
mark) is that for the pooled sample group.
a Also genotyped in the sample group with FCHL.
Table 6
Clinical Characteristics of the Families with FCHL
Affecteda
( )np 64
Unaffected
( )np 75
Age (years) 49.0  14.1 45.0  16.8
Sex (% males) 48 39
BMI (kg/m2) 28.3  4.1 25.5  3.6
HDL-C (mmol/liter) .94  .25 1.57  .42
TG (mmol/liter) 3.24  2.52 2.02  1.24
TC (mmol/liter) 6.78  1.32 6.85  1.27
Apolipoprotein:
A-I (mg/dl) 125  21 163  25
A-II (mg/dl) 38  9 43  7
NOTE.—All values except those for sex are expressed as mean 
SD. The affected group includes 21 probands with FCHL and 43 hypo-
a-lipoproteinemic family members.
a HDL-C levels !10th age- and sex-specific percentile.
35 (Clee et al. 2001). None of the nucleotide changes
showed cosegregation with low HDL-C in these
families.
Our analyses of well-defined Finnish families with low
HDL-C or FCHL revealed six loci that are potentially
important for the regulation of the HDL-C levels, on
chromosomes 2ptel, 2p, 3p, 8q23, 16q24.1-24.2, and
20q13.11. Three of these loci were supported by pooled
data analyses of the families with low HDL-C and
FCHL, whereas loci on chromosomes 2p and 3p ap-
peared to be specific to the families with low HDL-C
and another locus on chromosome 2ptel was seen only
in the analysis of the families with FCHL. The most
statistically significant result was observed on chromo-
some 8q23, with a two-point LOD score of 4.7 in the
pooled data analysis under a recessive mode of inheri-
tance. This chromosomal region has previously been
linked to the regulation of serum-HDL-C levels in a ge-
nome scan of a population cohort of Mexican American
families, who were not ascertained for the low-HDL-C
trait (Almasy et al. 1999). Our most significant markers
are located 20 cM centromeric from their peak markers.
These results, obtained independently both in a popu-
lation-based sample group and in well-defined families
with low HDL-C, implicate the involvement of one or
more genes in this region in the regulation of HDL-C.
On chromosome 16q, markers on an 18-cM region
showed suggestive evidence for linkage in the pooled
data analysis. Some evidence for linkage to this region
has also been reported in Dutch families with FCHL
(Aouizerat et al. 1999). Finally, on chromosome 20q,
markers spanning a 33-cM region produced suggestive
LOD scores. Previous analyses in both mouse studies
and human studies have indicated that chromosome 20q
harbors multiple loci that contribute to body adiposity,
fasting insulin levels, and type 2 DM (Bowden et al.
1997; Lembertas et al. 1997; Ghosh et al. 2000). Low
HDL-C is a common feature in type 2 DM, and these
findings may suggest the presence of one or more loci
on 20q12-13 that are involved in HDL-C metabolism.
Our results (1) have identified loci for low HDL-C in
the pooled data analysis of two Finnish sample groups
that were ascertained for overlapping traits and (2) have
suggested a partially shared genetic background for the
low-HDL-C and FCHL traits.
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